Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

OBJECTIVES: Our aim was to evaluate the safety and efficacy of ipilimumab combined with standard first-line chemotherapy for patients with extensive-stage SCLC. METHODS: Patients with chemotherapy-naive extensive-stage SCLC were treated with carboplatin and etoposide for up to six cycles. Ipilimumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Arriola, Edurne, Wheater, Matthew, Galea, Ian, Cross, Nadia, Maishman, Tom, Hamid, Debbie, Stanton, Louise, Cave, Judith, Geldart, Tom, Mulatero, Clive, Potter, Vannessa, Danson, Sarah, Woll, Pennella J., Griffiths, Richard, Nolan, Luke, Ottensmeier, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063510/
https://www.ncbi.nlm.nih.gov/pubmed/27296105
http://dx.doi.org/10.1016/j.jtho.2016.05.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063510/
https://www.ncbi.nlm.nih.gov/pubmed/27296105
http://dx.doi.org/10.1016/j.jtho.2016.05.028

Ejemplares similares